New MRI technique may predict chemo success earlier in breast cancer

NCT ID NCT05704062

Recruiting now Knowledge-focused Sponsor: Corewell Health East Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study is testing whether advanced MRI scans can predict how well breast cancer responds to chemotherapy earlier and more accurately than standard tumor size measurements. About 135 women scheduled for chemotherapy before surgery will receive additional MRI scans that measure tumor blood flow and cell density. The goal is to improve surgical planning and avoid over- or underestimating remaining cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Corewell Health William Beaumont University Hospital
RECRUITING

Royal Oak, Michigan, 48073, United States
OHSU Knight Cancer Institute
COMPLETED

Portland, Oregon, 97239, United States
University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States
University of Washington
RECRUITING

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.